775
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Defining in vitro topical antimicrobial and antibiofilm activity of epoxy-tigliane structures against oral pathogens

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2241326 | Received 18 Apr 2023, Accepted 20 Jul 2023, Published online: 31 Jul 2023

References

  • Schwarz F, Derks J, Monje A, et al. Peri-implantitis. J Clin Periodontol. 2018;45(Suppl 20):S246–S266. doi: 10.1111/jcpe.12954
  • Kordbacheh Changi K, Finkelstein J, Papapanou PN. Peri-implantitis prevalence, incidence rate, and risk factors: A study of electronic health records at a U.S. dental school. Clin Oral Implants Res. 2019;30(4):306–11. doi: 10.1111/clr.13416
  • Tonetti MS, Chapple IL, Jepsen S, et al. Primary and secondary prevention of periodontal and peri-implant diseases: introduction to, and objectives of the 11th European workshop on periodontology consensus conference. J Clin Periodontol. 2015;42(Suppl 16):S1–4. doi: 10.1111/jcpe.12382
  • Lafaurie GI, Sabogal MA, Castillo DM, et al. Microbiome and microbial biofilm profiles of peri-implantitis: A systematic review. J Periodontol. 2017;88(10):1066–1089. doi: 10.1902/jop.2017.170123
  • Hajishengallis G. The inflammophilic character of the periodontitis-associated microbiota. Mol Oral Microbiol. 2014;29(6):248–257. doi: 10.1111/omi.12065
  • Robitaille N, Reed DN, Walters JD, et al. Periodontal and peri-implant diseases: identical or fraternal infections? Mol Oral Microbiol. 2016;31(4):285–301. doi: 10.1111/omi.12124
  • Tamura N, Ochi M, Miyakawa H, et al. Analysis of bacterial flora associated with peri-implantitis using obligate anaerobic culture technique and 16S rDNA gene sequence. Int J Oral Maxillofac Implants. 2013;28(6):1521–1529. doi: 10.11607/jomi.2570
  • Wall IB, Davies CE, Hill KE, et al. Potential role of anaerobic cocci in impaired human wound healing. Wound Repair Regen. 2002;10(6):346–353. doi: 10.1046/j.1524-475X.2002.t01-1-10602.x
  • Neumann A, Björck L, Frick IM. Finegoldia magna, an anaerobic Gram-positive bacterium of the normal human microbiota, induces inflammation by activating neutrophils. Front Microbiol. 2020;11:65. doi: 10.3389/fmicb.2020.00065
  • Roos-Jansaker AM, Almhojd US, Jansson H. Treatment of peri-implantitis: clinical outcome of chloramine as an adjunctive to non-surgical therapy, a randomized clinical trial. Clin Oral Implants Res. 2017;28(1):43–48. doi: 10.1111/clr.12612
  • Hallstrom H, Persson GR, Lindgren S, et al. Open flap debridement of peri-implantitis with or without adjunctive systemic antibiotics: A randomized clinical trial. J Clin Periodontol. 2017;44(12):1285–1293. doi: 10.1111/jcpe.12805
  • Zakir M, Adams R, Farnell D, et al. A systematic review and meta-analysis of adjunctive physical, chemical, and biological treatments of peri-implantitis. J Oral Implantol. 2023;49:168–178. doi: 10.1563/aaid-joi-D-21-00204
  • Moses RL, Boyle GM, Howard-Jones RA, et al. Novel epoxy-tiglianes stimulate skin keratinocyte wound healing responses and re-epithelialization via protein kinase C activation. Biochem Pharmacol. 2020;178:114048. doi: 10.1016/j.bcp.2020.114048
  • Barnett CME, Broit N, Yap PY, et al. Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester tigilanol tiglate. Invest New Drugs. 2019;37(1):1–8. doi: 10.1007/s10637-018-0604-y
  • Powell LC, Cullen JK, Boyle GM, et al. Topical, immunomodulatory epoxy-tiglianes induce biofilm disruption and healing in acute and chronic skin wounds. Sci Transl Med. 2022;14(662):eabn3758. doi: 10.1126/scitranslmed.abn3758
  • Boyle GM, D’Souza MMA, Pierce CJ, et al. Intra-lesional injection of the novel PKC activator EBC-46 rapidly ablates tumors in mouse models. PLoS One. 2014;9(10):e108887. doi: 10.1371/journal.pone.0108887
  • Jorgensen JH, Turnidge JD, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray P, Baron E, Pfaller M, Jorgensen J, and Yolken R, editors. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press; 1999. p. 1526–1543.
  • Cowley NL, Forbes S, Amézquita A, et al. Effects of formulation on microbicide potency and mitigation of the development of bacterial insusceptibility. Appl Environ Microbiol. 2015;81(20):7330–7338. doi: 10.1128/AEM.01985-15
  • Eini A, Sol A, Coppenhagen-Glazer S, et al. Oxygen deprivation affects the antimicrobial action of LL-37 as determined by microplate real-time kinetic measurements under anaerobic conditions. Anaerobe. 2013;22:20–24. doi: 10.1016/j.anaerobe.2013.04.014
  • McLean DT, Lundy FT, Timson DJ. IQ-motif peptides as novel anti-microbial agents. Biochimie. 2013;95:875–880. doi: 10.1016/j.biochi.2012.12.004
  • Powell LC, Pritchard MF, Ferguson EL, et al. Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides. NPJ Biofilms Microbiomes. 2018;4(1):4. doi: 10.1038/s41522-018-0056-3
  • Heydorn A, Nielsen AT, Hentzer M, et al. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology-Uk. 2000;146(10):2395–2407. doi: 10.1099/00221287-146-10-2395
  • Escribano M, Figuero E, Martín C, et al. Efficacy of adjunctive anti-plaque chemical agents: a systematic review and network meta-analyses of the turesky modification of the Quigley and hein plaque index. J Clin Periodontol. 2016;43(12):1059–1073. doi: 10.1111/jcpe.12616
  • Figuero E, Herrera D, Tobias A, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: A systematic review and network meta-analyses. J Clin Periodontol. 2019;46:723–739. doi: 10.1111/jcpe.13127
  • Serrano J, Escribano M, Roldán S, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: a systematic review and meta-analysis. J Clin Periodontol. 2015;42(Suppl 16):S106–138. doi: 10.1111/jcpe.12331
  • Oludiran A, Courson DS, Stuart MD, et al. How oxygen availability affects the antimicrobial efficacy of host defense peptides: Lessons learned from studying the copper-binding peptides piscidins 1 and 3. Int J Mol Sci. 2019;20(21):5289. doi: 10.3390/ijms20215289
  • Cullen JK, Boyle GM, Yap PY, et al. Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes. Sci Rep. 2021;11(1):207. doi: 10.1038/s41598-020-80397-9
  • Filipuzzi I, Fabbro D, Imber R. Unphosphorylated alpha-PKC exhibits phorbol ester binding but lacks protein kinase activity in vitro. J Cell Biochem. 1993;52:78–83. doi: 10.1002/jcb.240520111
  • National Institutes of Health. Research On Microbial Biofilms Report No: PA-03-047 Available at: https://grants.nih.gov/grants/guide/pa-files/PA-03-047.html. Accessed: September 15.
  • Karygianni L, Ren Z, Koo H, et al. Biofilm matrixome: Extracellular components in structured microbial communities. Trends Microbiol. 2020;28(8):668–681. doi: 10.1016/j.tim.2020.03.016
  • Powell LC, Sowedan A, Khan S, et al. The effect of alginate oligosaccharides on the mechanical properties of Gram-negative biofilms. Biofouling. 2013;29(4):413–421. doi: 10.1080/08927014.2013.777954
  • Sculean A, Gruber R, Bosshardt DD. Soft tissue wound healing around teeth and dental implants. J Clin Periodontol. 2014;41(Suppl 15):S6–22. doi: 10.1111/jcpe.12206
  • Pundir P, Catalli A, Leggiadro C, et al. Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor. Mucosal Immunol. 2014;7(1):177–187. doi: 10.1038/mi.2013.37
  • Dagli N, Dagli R, Mahmoud RS, et al. Essential oils, their therapeutic properties, and implication in dentistry: A review. J Int Soc Prev Community Dent. 2015;5(5):335–340. doi: 10.4103/2231-0762.165933
  • Hotta M, Nakata R, Katsukawa M, et al. Carvacrol, a component of thyme oil, activates PPARα and γ and suppresses COX-2 expression. J Lipid Res. 2010;51(1):132–139. doi: 10.1194/jlr.M900255-JLR200
  • Hart PH, Brand C, Carson CF, et al. Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree oil), suppresses inflammatory mediator production by activated human monocytes. Inflamm Res. 2000;49(11):619–626. doi: 10.1007/s000110050639
  • Nogueira MNM, Aquino SG, Rossa Junior C, et al. Terpinen-4-ol and alpha-terpineol (tea tree oil components) inhibit the production of IL-1β, IL-6 and IL-10 on human macrophages. Inflamm Res. 2014;63(9):769–778. doi: 10.1007/s00011-014-0749-x
  • Panizza BJ, de Souza P, Cooper A, et al. Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46). EBioMedicine. 2019;50:433–441. doi: 10.1016/j.ebiom.2019.11.037
  • Miller J, Campbell J, Blum A, et al. Dose characterization of the investigational anticancer drug tigilanol tiglate (EBC-46) in the local treatment of canine mast cell tumors. Front Vet Sci. 2019;6:106. doi: 10.3389/fvets.2019.00106
  • Petersilka GJ, Ehmke B, Flemmig TF. Antimicrobial effects of mechanical debridement. Periodontol. 2002;28:56–71. doi: 10.1034/j.1600-0757.2002.280103.x
  • Renvert S, Roos-Jansåker AM, Claffey N. Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol. 2008;35:305–315. doi: 10.1111/j.1600-051X.2008.01276.x
  • Kensara A, Hefni E, Williams MA, et al. Microbiological profile and human immune response associated with peri-implantitis: A systematic review. J Prosthodont. 2021;30(3):210–234. doi: 10.1111/jopr.13270